Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022

We describe a gonorrhoea case with ceftriaxone plus high-level azithromycin resistance. In April 2022, an Austrian heterosexual male was diagnosed with gonorrhoea after sexual intercourse with a female sex worker in Cambodia. Recommended treatment with ceftriaxone (1 g) plus azithromycin (1.5 g) pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Pleininger, Sonja, Indra, Alexander, Golparian, Daniel, Heger, Florian, Schindler, Stefanie, Jacobsson, Susanne, Heidler, Stefan, Unemo, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205165/
https://www.ncbi.nlm.nih.gov/pubmed/35713023
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.24.2200455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205165/
https://www.ncbi.nlm.nih.gov/pubmed/35713023
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.24.2200455

Ejemplares similares